Weight Loss Injections May Require Lifelong Use, Research Indicates
New evidence suggests that popular weight loss injections Mounjaro and Wegovy may need to be taken indefinitely to effectively manage obesity. This revelation raises concerns for many individuals already struggling with the high costs of treatment, which can reach up to £300 per month.
Current Usage and Costs
In the past year, nearly two million adults in the UK have opted for these weight loss medications, predominantly paying out of pocket. A significant number of users, approximately 50%, discontinue the treatment within the first year due to adverse side effects or financial constraints. Research published in the British Medical Journal indicates that most individuals tend to regain the weight they lost within an average of just 18 months after stopping the injections.
Expert Insights
Professor Susan Jebb of the University of Oxford, a specialist in diet and population health, points out the implications of these findings. She highlights that individuals who are genetically predisposed to obesity may require long-term assistance to maintain weight loss. Jebb noted that the question remains unresolved regarding how to best assist individuals in keeping the weight off after they stop medication.
The Case of Rosie Parsons
One individual affected by this issue is Rosie Parsons, who lost eight stone while taking Wegovy. Although she initially saw significant results, she struggled to justify the ongoing expense of around £175 a month as her weight loss plateaued. After attempting Mounjaro but experiencing intolerable side effects, she ceased treatment and subsequently gained back four stone in just four months. Parsons expressed her challenges with managing sugar cravings without the injections, noting the impact of rising costs on her ability to maintain treatment.
Understanding Obesity and Treatment Limitations
Research indicates that genetics plays a considerable role in the risk of obesity, accounting for an estimated 40% to 70% of the likelihood. While the use of weight loss drugs can be effective, they do not provide a permanent solution. Studies suggest that once individuals stop using these medications, the rate of weight gain can increase dramatically, exceeding the rate of weight re-gain seen after conventional dieting.
According to Sam West, another researcher from Oxford, although these drugs are effective while being used, they do not offer a long-term fix. When treatment ceases, the biological mechanisms that lead to weight gain may reactivate rapidly.
Background
The growing prevalence of obesity has prompted increased focus on pharmaceutical interventions. In recent years, medications like Mounjaro and Wegovy have gained traction as means to manage obesity, particularly as traditional methods such as diet and exercise may not suffice for many. The ongoing debate about long-term treatment solutions highlights the need for further research and support for individuals battling obesity.
Source: Original Article
